MENU
FEB 20, 2017 8:00 AM PST

SPR - Companion from bench to bedside

Speaker
  • Professor, RWTH Aachen University
    Biography
      Markus studied biology at the RWTH Aachen university and joined the group of Rainer Fischer in 1996, then at the department of botany headed by Prof. Kreuzaler where I earned my diploma in biology in 1998 and continued to work at the newly formed department of molecular biology headed by Prof. Fischer. The majority of assays developed were not kinetic assays, but rather the quantification and characterization of various quality attributes of recombinant produced proteins. For almost 20 years, Markus has been in charge of the SPR unit at the Institute for Molecular Biotechnology at the RWTH University and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen. Within this environment SPR is being applied everyday in basic and applied research, from small molecules to antibodies and viruses.

    Abstract

    SPR technology is being improved steadily and today is an essential component in the biopharmaceutical industry. As SPR based assays extract valuable and reliable information at high accuracy and precision they also provide huge advantages and opportunities for basic and applied research. Progress in synthetic biology and scalable transient gene expression systems is rapidly expanding not only the demand but also increasing the repertoire and quality of reagents for molecular recognition studies. We use SPR assays for a huge variety of tasks within a multi-user facility and are particularly interested in using plant-based systems for the discovery, development and production of biopharmaceuticals. The practical uses and applications to plant-produced antibodies and malaria vaccine development will be illustrated.

    Focusing on protein cocktails, questions addressing their identity, composition, and potency will be discussed. SPR based assays are not only considered to be instrumental to advance such products into the clinic but will play an equally important role for studying their behavior and efficacy in patients.


    Show Resources
    You May Also Like
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources
    Attendees
    • See more